Jeffrey Chodakewitz
2018
Compensation breakdown
Non-Equity Incentive Plan | $550,638 |
---|---|
Option Awards | $1,364,130 |
Salary | $618,000 |
Stock Awards | $3,150,448 |
Other | $13,780 |
Total | $5,696,996 |
Chodakewitz received $3.2M in stock awards, accounting for 55% of the total pay in 2018.
Chodakewitz also received $550.6K in non-equity incentive plan, $1.4M in option awards, $618K in salary and $13.8K in other compensation.
Rankings
In 2018, Jeffrey Chodakewitz's compensation ranked 1,688th out of 14,244 executives tracked by ExecPay. In other words, Chodakewitz earned more than 88.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,688 | 88th |
Manufacturing | 597 | 90th |
Chemicals And Allied Products | 191 | 91st |
Drugs | 152 | 92nd |
Pharmaceutical Preparations | 113 | 92nd |
Pay ratio
Jeffrey Chodakewitz's Pay | $5,696,996 |
---|---|
Median Employee's Pay | $232,178 |
Pay Ratio | 25to 1 |
In 2018, the annual total compensation of Jeffrey Chodakewitz was $5,696,996.
The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.
The ratio of Jeffrey Chodakewitz's pay to the pay of median employee was therefore 25 to one.
Chodakewitz's colleagues
We found six more compensation records of executives who worked with Jeffrey Chodakewitz at Vertex Pharmaceuticals in 2018.
2018
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2018
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2018
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2018
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2018
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2018
Thomas Graney
Vertex Pharmaceuticals